đź“‹ FDA Reference

nocc hydrophilic wound dressing

Kytogenics

Summary: The nocc hydrophilic wound dressing by Kytogenics is a medical device used for wound management, particularly in cases requiring moisture retention and controlled drug release. It is commonly used by wound care specialists and in surgical settings.

FDA Clearance Information

Pathway 510K
Decision Date March 14, 2008
Product Code KGN
Device Class —
Evidence 419 studies

The nocc hydrophilic wound dressing was cleared via the FDA 510(k) pathway on March 14, 2008. Manufactured by Kytogenics, it is classified under product code KGN with no specific class designation.

What It Is

The nocc hydrophilic wound dressing is a specialized dressing designed to manage wounds by maintaining a moist environment conducive to healing. It incorporates N,O-carboxymethyl chitosan, a variant of chitosan known for its high degradation rate, allowing for immediate drug release. This dressing is particularly useful in delivering topical anti-infectives like mupirocin directly to the wound site.

Clinical Applications

This dressing is commonly used in wound care management, particularly for chronic wounds, surgical incisions, and burns. It is suitable for use in both inpatient and outpatient settings, including hospitals and specialized wound care clinics. The device is particularly beneficial for patients requiring controlled drug delivery and moisture retention to promote healing.

Indications for Use

The nocc hydrophilic wound dressing is indicated for use in managing wounds that benefit from a moist environment and controlled release of medications. It is suitable for patients with chronic wounds, surgical wounds, and burns.

Practical Considerations

The dressing is available in various sizes to accommodate different wound types and sizes. It is compatible with standard wound care protocols and can be used in conjunction with other wound management strategies. Proper application technique is essential to ensure optimal drug release and moisture retention.

Related Literature

The linked study investigated the development of a hybrid biomaterial ink using starch and N,O-carboxymethyl chitosan for 3D-printed wound dressings. The study found that varying the ratio of these components affects the degradation and drug release characteristics. Mupirocin was successfully incorporated into the biomaterial, demonstrating potential for controlled drug delivery. Limitations include the need for further clinical trials to validate efficacy in real-world settings.

Linked Studies (20)

PubMed • 2025

Onyx Liquid Embolic Agent: Basic Knowledge for Its Use in Interventional Neuroradiology.

Journal of neuroendovascular therapy

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Performance evaluation of quantitative hemoglobin A2 and fetal hemoglobin testing using commercially lyophilized vs. in-house whole blood controls in Chinese clinical laboratories: a 12-year analysis of National External Quality Assessment Data.

Clinical chemistry and laboratory medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical progress note: Haemophilus influenzae type b.

Journal of hospital medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Pilot study of social media promotion of home-based self-testing for syphilis.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Clinical development and performance of the First to Know Syphilis Self-Test for over-the-counter usage: a de novo rapid test for treponemal antibody.

Journal of clinical microbiology

View Source →
PubMed • 2025

Implementation of an Opt-Out and Rapid Point-of-Care Syphilis Testing Program for Pregnant Patients Presenting to the Emergency Department.

Sexually transmitted diseases

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Evaluation of Rapid Syphilis Testing Using the Syphilis Health Check in Florida, 2015-2016.

Florida public health review

View Source →
PubMed • 2025

Multiplex droplet digital PCR for the detection and quantitation of Streptococcus pneumoniae, Mycoplasma pneumoniae, and Haemophilus influenzae.

Frontiers in cellular and infection microbiology

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR/Cas12a.

Transboundary and emerging diseases

View Source →
PubMed • 2025

Tp40: a new potential prognostic and diagnostic marker for syphilis.

Microbiology spectrum

View Source →
PubMed • 2025

Serotonin sets up neutrophil extracellular traps to promote neuroendocrine prostate cancer metastasis in the liver.

The Journal of clinical investigation

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Application value of Philips Ingenuity TF PET/CT scanner imaging agent FAP in evaluating renal fibrosis.

Hellenic journal of nuclear medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Message from Dr. Philippe T. Georgel, Guest Editor for the Marshall University Collection, Brad D. Smith, President of Marshall University, and Dr. Anivandan Mukherjee, Provost of Marshall University.

Biochemistry and cell biology = Biochimie et biologie cellulaire

View Source →
PubMed • 2025

Editorial - Philippe Ascher (1936-2022).

Neuroscience

View Source →
PubMed • 2025

Improved patient comfort and procedural efficiency using chlorhexidine-coated hydrophilic urethral catheters: a randomized controlled trial.

Journal of Yeungnam medical science

RCT View Source →
PubMed • 2025

pTx-Pulseq in hybrid sequences: Accessible and advanced hybrid open-source MRI sequences on Philips scanners.

Magnetic resonance in medicine

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Comparative connectomics of Drosophila descending and ascending neurons.

Nature

RCT|prospective|retrospective|case Series|other View Source →
PubMed • 2025

Hydrophilic-coated sheaths for reducing radial artery spasm during transradial procedures: A systematic review and meta-analysis.

Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences

View Source →
PubMed • 2025

History of antineutrophil cytoplasmic autoantibodies : Milestones in rheumatology.

Zeitschrift fur Rheumatologie

View Source →
PubMed • 2025

A Hydrophilic Polyurethane Foam Containing Nigella sativa Oil as a Wound Dressing.

BioMed research international

RCT|prospective|retrospective|case Series|other View Source →

Frequently Asked Questions

What is nocc hydrophilic wound dressing used for?

It is used for managing wounds that require moisture retention and controlled drug release, such as chronic wounds, surgical incisions, and burns.

What specialties typically use this device?

Wound care specialists, surgeons, and clinicians in both hospital and outpatient settings commonly use this device.

What are the FDA-cleared indications?

The device is indicated for managing wounds that benefit from a moist environment and controlled drug release, including chronic wounds and surgical sites.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 Stay Updated

Get the latest vascular education content delivered to your inbox.